TTY Biopharm Company Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% | 3 | $372.17B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | Buy/Sell | £165.99 | 34.64% | 16 | £187.73B |
| NOVN | Novartis | Hold |
10
|
CHF93.37 | Buy/Sell | CHF105.00 | 15.26% | 9 | CHF190.51B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | Buy/Sell | $118.92 | 21.53% | 7 | $181.08B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.39B |
| CSL | CSL | Outperform |
12
|
$280.00 | Buy/Sell | $205.51 | -26.62% | 5 | $135.31B |
| BAX | Baxter International Inc | Hold |
17
|
$35.25 | Buy/Sell | $44.86 | 24.82% | 5 | $17.96B |
| 1093 | CSPC Pharmaceutical Group | Buy |
18
|
HK$6.62 | Buy/Sell | HK$9.50 | 40.18% | 6 | HK$80.07B |
| 4142 | Adimmune | - |
10
|
NT$31.05 | Buy/Sell | NT$55.00 | -100.00% | 0 | NT$14.08B |
| PSTV | Plus Therapeutics | Buy |
11
|
$2.24 | Buy/Sell | $11.00 | 569.64% | 2 | $9.92M |